Log in or Sign up for Free to view tailored content for your specialty!
Regulatory/Legislative News
FDA clears Xen for refractory glaucoma
The FDA has cleared Allergan’s Xen glaucoma treatment system for refractory glaucoma, according to a company press release.
PLEX Elite 9000 from Zeiss receives FDA clearance
The FDA has cleared the PLEX Elite 9000 for advanced retina research, Carl Zeiss Meditec announced in a press release.
Log in or Sign up for Free to view tailored content for your specialty!
FDA releases final guidance on medical device reporting for manufacturers

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
FDA takes action in October
In October, the FDA approved, cleared, responded to and issued review status for products and devices in the ophthalmic space. Here are the articles:
New CPT codes to cover programming of Argus II retinal prosthesis system
The American Medical Association Current Procedural Terminology Editorial Panel approved two new Category III CPT codes for programming the Argus II retinal prosthesis system, Second Sight Medical Products announced in a press release.
Boo! PQRS, Value Modifier penalties for 2017 sure to scare you

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
MACRA rule may help ophthalmologists avoid penalties

CHICAGO — The recently finalized MACRA rule from the Centers for Medicare and Medicare Services may help ophthalmologists avoid penalties by shifting physician payments from a volume based payment program to a value based payment program, according to speakers here.
CMS plans to overhaul Medicare’s beneficiary identification system: What you need to know

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
Professional society co-management guidelines: Where do they disagree?

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
Pay careful attention regarding evaluation and management services and the global surgery period

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.
-
Headline News
FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide
March 13, 20254 min read -
Headline News
Sleep duration a predictor of high blood pressure in teens regardless of insomnia
March 14, 20252 min read -
Headline News
Additional support may be key to combat shortages in nephrology workforce
March 10, 20257 min read
-
Headline News
FDA issues limited acne product recalls, AAD releases statement on benzoyl peroxide
March 13, 20254 min read -
Headline News
Sleep duration a predictor of high blood pressure in teens regardless of insomnia
March 14, 20252 min read -
Headline News
Additional support may be key to combat shortages in nephrology workforce
March 10, 20257 min read